Figure 5From: The novel mTOR inhibitor CCI-779 (temsirolimus) induces antiproliferative effects through inhibition of mTOR in Bel-7402 liver cancer cellsCCI-779 induces G1/S cell cycle arrest in Bel-7402 cells. CCI-779 treatment for 48 h and cell cycle analysis by flow cytometry. (Ctr), control without CCI-779; (1), treatment with 5 μM CCI-779 for 48 h.Back to article page